FDA analysis of J&J COVID vaccine booster sets the stage for public hearing
Johnson & Johnson has asked the Food and Drug Administration to authorize a booster for people 18 and older six months after initial immunization, with an option to vaccinate after two months.
Read more on NPR
Wednesday, 13 October 2021
FDA analysis of J&J COVID vaccine booster sets the stage for public hearing
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.